Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand
Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial) - eBioMedicine